Skip to main content

Behavioral therapy added to pediatric antidepressant treatment reduces likelihood of relapse

Photo source:Β WikiMedia Commons

Exposure to ACEs can lead to depression. New research suggests how we can better treat children suffering from this.

Cognitive behavioral therapy in addition to medication improves the long-term success of treatment for children and adolescents suffering from depression, a new UT Southwestern Medical Center study indicates.

Based on the results of a clinical trial conducted at UT Southwestern and Children's Medical Center of Dallas, depression relapse rates were substantially lower in a group of youth who received both forms of treatment versus medication alone.

"Continuation-phase strategies designed to reduce the high rates of relapse in depressed youths have important public health implications, as recurrence of depression is more likely in youths with multiple episodes," said Dr. Betsy Kennard, Professor of Psychiatry at UT Southwestern and senior author of the study published June 17 inΒ The American Journal of Psychiatry.

Relapse rates in youth with major depressive disorders typically range from 40 percent to 70 percent, said Dr. Kennard, also Director of an outpatient program at Children's Medical Center called Suicide Prevention and Resilience at Children's (SPARC).

In this study, the relapse rate for the group of 75 youth who received behavioral therapy for six months following six weeks of initial treatment with the antidepressant fluoxetine, also known as Prozac, was 9 percent. Among the group of 69 youth who received only the drug during this period, 26.5 percent relapsed.

http://www.sciencedaily.com/releases/2014/07/140702110746.htm

Add Comment

Comments (0)

Post
Copyright Β© 2023, PACEsConnection. All rights reserved.
×
×
×
×
Link copied to your clipboard.
×